tm
Seeing Is Believing
tm
Seeing Is Believing
BTTX is currently covered by 2 analysts with an average price target of $6.3. This is a potential upside of $6.3 (0%) from yesterday's end of day stock price of $0.
Better Therapeutics's activity chart (see below) currently has 2 price targets and 9 ratings on display. The stock rating distribution of BTTX is 100% BUY.
Highest price target for BTTX is $3, Lowest price target is $1, average price target is $6.3.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 10-Aug-2023. First documented stock forecast 24-Nov-2021.
Currently out of the existing stock ratings of BTTX, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 3 months 21 days ago
(10-Aug-2023)
0/2 (0%)
$10.32 (154.49%)
Buy
$3
$2.85 (1900.00%)
$5
1 years 3 months 21 days ago
(10-Aug-2023)
0/2 (0%)
$2.27 (310.96%)
What is BTTX (Better Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BTTX (Better Therapeutics) with a proven track record?
Which analyst has the current lower performing score on BTTX (Better Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BTTX (Better Therapeutics)?
Which analyst is the currently most bullish on BTTX (Better Therapeutics)?
Which analyst is the currently most reserved on BTTX (Better Therapeutics)?
